News for Equillium, Inc. (EQ)

Equillium (EQ) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Equillium (EQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Equillium (EQ) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Equillium (EQ) stock soared 26% on positive topline results from a Phase 2 study of the drug itolizumab in the treatment of moderate to severe ulcerative colitis. Read more here.

Equillium CFO Jason Keyes sells $6,500 in stock

Equillium stock touches 52-week low at $0.6 amid market challenges

Equillium (EQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Equillium shares downgraded to hold from buy

Shares of Carvana Co. CVNA rose in today's pre-market trading after the company reported better-than-expected third-quarter financial results. Carvana reported...

Christine Zedelmayer, Sr. Vice President and Chief Operating Officer of Equillium Inc (EQ), executed a sale of 15,000 shares of the company on October 28, 2024.

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium CFO Jason Keyes sells $8,100 in company stock

Equillium executive sells $32,985 in stock

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide therapyEquillium...

Loading... Loading... Shares of Core & Main Inc CNM fell sharply during Tuesday's session after the company reported mixed first-quarter financial results. Co...

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin...

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ... | January 4, 2023

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...